Skip to main content
Louis Weiner, MD, Oncology, Washington, DC

LouisMarcWeinerMD

Oncology • Washington, DC

Professor of Medicine, Georgetown University

Join to view full profile

Dr. Weiner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Weiner's full profile

Already have an account?

  • Office

    3970 Reservoir Rd Nw
    Lccc Georgetown University Medical Center Room E501
    Washington, DC 20007
    Phone+1 202-687-2110
    Fax+1 202-687-6402

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1984
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Internal Medicine, 1977 - 1981
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1977

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2008 - 2027
  • PA State Medical License
    PA State Medical License 1984 - 2022
  • VT State Medical License
    VT State Medical License 1978 - 1984
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Top Doctors:Washington DC Area Castle Connolly, 2012
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Researcher Talks Bridging the Valley of Death
    Researcher Talks Bridging the Valley of DeathJanuary 24th, 2025
  • Title: How Two Doctors Are Using Research to Push the Field of Medicine
    Title: How Two Doctors Are Using Research to Push the Field of MedicineMay 25th, 2023
  • Key Studies Conducted at Georgetown Lombardi Lead to Better Treatment for People with Melanoma
    Key Studies Conducted at Georgetown Lombardi Lead to Better Treatment for People with MelanomaMarch 1st, 2023
  • Join now to see all

Grant Support

  • Determinants Of Tumor Sensitivity To Egfr-Targeted AntibodiesNational Cancer Institute2009–2012
  • Tissue Culture Shared ResourceNational Cancer Institute2010–2011
  • Senior LeadershipNational Cancer Institute2010–2011
  • Protocol-Specific Research SupportNational Cancer Institute2010–2011
  • Protocol Review And Monitoring SystemNational Cancer Institute2010–2011
  • Proteomics And MetabolomicsNational Cancer Institute2010–2011
  • Program LeadersNational Cancer Institute2010–2011
  • Preclinical Imaging Research LaboratoryNational Cancer Institute2010–2011
  • Planning And EvaluationNational Cancer Institute2010–2011
  • Novel Targets In Endocrine ResponsivenessNational Cancer Institute2010–2011
  • Microscopy And ImagingNational Cancer Institute2010–2011
  • Histopathology And TissueNational Cancer Institute2010–2011
  • Georgetown University, Lombardi Cancer Center Support Grant Competitive RenewalNational Cancer Institute2010–2011
  • Genomics And EpigenomicsNational Cancer Institute2010–2011
  • Flow Cytometry/Cell SortingNational Cancer Institute2010–2011
  • Familial Cancer RegistryNational Cancer Institute2010–2011
  • Developmental FundsNational Cancer Institute2010–2011
  • Data And Safety Monitoring/Nih PolicyNational Cancer Institute2010–2011
  • Clinical Research Management OfficeNational Cancer Institute2010–2011
  • Clinical And Molecular EpidmiologyNational Cancer Institute2010–2011
  • Biostatistics And BioinformaticsNational Cancer Institute2010–2011
  • Animal Shared ResourceNational Cancer Institute2010–2011
  • AdministrationNational Cancer Institute2010–2011
  • Adaptive Immunity From High Affinity Anti-Her2/Neu Monoclonal AntibodiesNational Cancer Institute2008–2010
  • Cancer Center Support GrantNational Cancer Institute2006–2009
  • Monoclonal Antibody Therapy Induction Of Adaptive ImmunityNational Cancer Institute2008
  • Monoclonal Antibody Therapy Induction Of Adaptive ImmunityNational Cancer Institute2007
  • Adaptive Immunity From High Affinity Anti-Her2/Neu Monoclonal AntibodiesNational Cancer Institute2006–2007
  • Antibody-Targeted NK Cell Activation For Cancer TherapyNational Cancer Institute2003–2007
  • Guava Personal Cell Analysis-96 System: CancerNational Center For Research Resources2006
  • Guava Easycyte Base System (Guava Personal Cell Analysis-96 System)National Center For Research Resources2006
  • Gene Expression In Circulating Tumor CellsNational Cancer Institute2005–2006
  • Conference On Antibody-Based Therapeutics For CancerNational Cancer Institute2004
  • Gene Expression In Circulating Tumor CellsNational Cancer Institute2003
  • Antibody-Based Therapeutics For CancerNational Cancer Institute2003
  • Tumor And Endothelial Cells As Drug Targets In BloodNational Cancer Institute2002–2003
  • Antibody-Targeted Immunotherapy Of CancerNational Cancer Institute1999–2002
  • Tumor Targeting By Single Chain FV MoleculesNational Cancer Institute1997–2002
  • Eastern Cooperative Oncology GroupNational Cancer Institute1996–2002
  • Clinical Oncology Research Career Development ProgramNational Cancer Institute1992–2001
  • Tumor Targeting By Single-Chain FV MoleculesNational Cancer Institute1996–1998
  • Targeted Immunotherapy Using Bispecific AntibodiesNational Cancer Institute1996–1998
  • Clinical Development Of 2B1 Bispecific Monoclonal ABNational Cancer Institute1993–1996
  • Bispecific Anti-Tumor FC Gamma R III Monoclonal AntibodyNational Cancer Institute1993–1995
  • Bispecific Anti-Tumor/Fcyr III Monoclonal AntibodiesNational Cancer Institute1989–1991
  • NCI Clinical Investigator Award ProgramNational Cancer Institute1986–1988

Professional Memberships

Dr. Louis Weiner, Dr. Louis Weiner, MD, Dr. L Weiner, Dr. Louis Marc Weiner